People may be vaccinated with the vaccine from pharmaceutical AstraZeneca by the end of this year. That says CEO Pascal Soriot of the company in the Swedish newspaper on Saturday Today’s News.
Exactly when the vaccine can be used depends on regulatory approval. “If they act quickly when our vaccine is ready, we can start vaccinating people in January, maybe even by the end of December,” Soriot said.
The British-Swedish pharmaceutical company is collaborating with the University of Oxford on a corona vaccine. The potential vaccine is currently in its third stage of development. This means that the drug is tested on tens of thousands of people.
Research into the vaccine was halted for a week in September after one of the British subjects developed potentially serious side effects. After the UK government’s oversight committee concluded that it was safe to proceed, the investigation could be resumed.
The potential vaccine from AstraZeneca is seen by the WHO health organization as the most promising. The European Commission has already signed a deal with AstraZeneca and hopes to receive 300 million doses if the vaccine is approved.